FindTrial
Sign In

To Evaluate the Efficacy of Eladi Kashaya by oral route in the management of Raktapradar

RANDOMIZED CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY OF ELADI KASHAYA AND PRADARANTAK RAS IN THE MANAGEMENT OF RAKTAPRADAR (ABNORMAL UTERINE BLEEDING) - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112160
Enrollment
92
Registered
2026-06-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified Health Condition 2: Z00-Z13- Persons encountering health services for examinations

Interventions

Intervention1: Eladi Kashaya: Oral drug therapy Intervention2: Eladi Kashaya: Reference Harita samhita, adhobhakta kaal, 40ml bid for 2 months, Anupan sharkara Control Intervention1: Pardarantak ras:

Sponsors

CSMSS Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad Maharashtra India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient having symptoms of raktapradar, Patient with intermenstrual bleeding, HB percentage of 8 gram percent and above

Exclusion criteria

Exclusion criteria: Diagnosed patients with uterine and pelvic pathology, Diagnosed patient with any serious systemic disorder, Known case of abortion or ectopic pregnancy , Patient taking anti coagulation therapy and coagulant defects HB percentage of less than 8 gram percent

Design outcomes

Primary

MeasureTime frame
To decrease the increased amount and duration of bleeding. To decrease the other symptoms like Aadhoudarshool, Katishool Angamarda Timepoint: 90 days—

Secondary

MeasureTime frame
1.To compare the efficacy of eladi kashaya and pradarantak ras in the management of Raktapradar( Abnormal uterine bleeding) 2. To study the details of raktapradar according to Ayurveda 3. To study the details of abnormal uterine bleeding according to modern.Timepoint: 90 Days—

Countries

India

Contacts

Public ContactDr Ruchita Uttam Rathod

CSMSS AYURVED MAHAVIDHYALAYA AND RUGNALAYA KANCHANWADI AURANGABAD

amolhavale@gmail.com9822538957

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026